These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6945922

  • 1. Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.
    Harris AL, Grahame-Smith DG.
    Cancer Chemother Pharmacol; 1981; 5(3):185-92. PubMed ID: 6945922
    [Abstract] [Full Text] [Related]

  • 2. Efficient formation of cytosine arabinoside-5'-triphosphate in leukemic blasts of human T-cell acute lymphoblastic leukemia.
    Tanaka M, Yoshida S.
    Leuk Res; 1989; 13(10):931-6. PubMed ID: 2586146
    [Abstract] [Full Text] [Related]

  • 3. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Bhalla K, McCrady C.
    Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
    [Abstract] [Full Text] [Related]

  • 4. Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
    Harris AL, Grahame-Smith DG, Potter CG, Bunch C.
    Clin Sci (Lond); 1981 Feb; 60(2):191-8. PubMed ID: 6940687
    [Abstract] [Full Text] [Related]

  • 5. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 6. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Chemother Pharmacol; 1992 Dec; 31(1):11-7. PubMed ID: 1458554
    [Abstract] [Full Text] [Related]

  • 7. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 8. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ.
    Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322
    [Abstract] [Full Text] [Related]

  • 9. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
    Tanaka M, Yoshida S.
    Jpn J Cancer Res; 1987 Aug 01; 78(8):851-7. PubMed ID: 3115933
    [Abstract] [Full Text] [Related]

  • 10. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333
    [Abstract] [Full Text] [Related]

  • 11. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
    Tanaka M.
    Leuk Res; 1993 Jul 15; 17(7):585-92. PubMed ID: 8326741
    [Abstract] [Full Text] [Related]

  • 12. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
    Fridland A, Verhoef V.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):262-8. PubMed ID: 3035721
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Res; 1988 Jan 15; 48(2):329-34. PubMed ID: 3335008
    [Abstract] [Full Text] [Related]

  • 14. Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.
    Grant S, Jarvis WD, Turner AJ, Wallace HJ, Pettit GR.
    Br J Haematol; 1992 Nov 15; 82(3):522-8. PubMed ID: 1486032
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI, Mecum RA, Nyce J, Steele DA, Holcenberg JS.
    Cancer Chemother Pharmacol; 1989 Nov 15; 24(4):203-10. PubMed ID: 2473850
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Hug V, Keating MJ, Chubb S.
    Cancer Res; 1980 Mar 15; 40(3):588-91. PubMed ID: 6937239
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
    Roberts D, Peck C, Hilliard S, Wingo W.
    Cancer Res; 1979 Oct 15; 39(10):4048-54. PubMed ID: 476642
    [Abstract] [Full Text] [Related]

  • 18. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
    Gandhi V, Estey E, Du M, Keating MJ, Plunkett W.
    Clin Cancer Res; 1997 Sep 15; 3(9):1539-45. PubMed ID: 9815841
    [Abstract] [Full Text] [Related]

  • 19. Deoxycytidine kinase, thymidine kinase and cytidine deaminase and the formation of Ara-CTP in leukemic cells in different phases of the cell cycle.
    Richel DJ, Colly LP, Arentsen-Honders MW, Starrenburg CW, Willemze R.
    Leuk Res; 1990 Sep 15; 14(4):363-9. PubMed ID: 2159090
    [Abstract] [Full Text] [Related]

  • 20. On the interaction between cytosine arabinoside and etoposide in vivo and in vitro.
    Liliemark J, Knochenhauer E, Gruber A, Pettersson B, Björkholm M, Peterson C.
    Eur J Haematol; 1993 Jan 15; 50(1):22-5. PubMed ID: 8436210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.